Table 1.

Characteristics of the 79 Patients at Baseline.^*

Characteristic	Value
Median age (range) — yr	73 (24–93)
Male sex — no. (%)	67 (85)
Race — no. (%)†
White	69 (87)
Other	2 (3)
Not reported	8 (10)
Not Hispanic or Latinx — no. (%)†	74 (94)
Primary tumor site — no. (%)
Head and neck	72 (91)
Trunk, arms, and legs	7 (9)
Stage group — no. (%)‡
II	5 (6)
III	38 (48)
IV (M0)	36 (46)
Tumor stage at screening — no. (%)‡
TX	23 (29)
Tis	1 (1)
T1	4 (5)
T2	10 (13)
T3	39 (49)
T4a	2 (3)
Node stage at screening — no. (%)‡
NX	1 (1)
N0	31 (39)
N1	13 (16)
N2§	11 (14)
N2b	9 (11)
N2c	1 (1)
N3¶	1 (1)
N3a	1 (1)
N3b	11 (14)
ECOG performance-status score — no. (%)∥
0	60 (76)
1	19 (24)

^*Percentages may not total 100 because of rounding.

^†Race and ethnic group were reported by the patient.

^‡Tumor–node–metastasis (TNM) staging of cutaneous squamous-cell carcinoma with involvement of the head and neck was based on the eighth edition of the American Joint Committee on Cancer Staging Manual, and TNM staging of cutaneous squamous-cell carcinoma without involvement of the head and neck was based on the ninth edition of the Union for International Cancer Control Manual of Clinical Oncology.

^§These values were not further specified as N2a, N2b, or N2c.

^¶These values were not further specified as N3a or N3b.

^∥Scores on the Eastern Cooperative Oncology Group (ECOG) performance-status scale range from 0 to 5, with higher scores indicating greater disability.